Cost implications of implementation of pathogen-inactivated platelets

BACKGROUND: Pathogen inactivation (PI) is a new approach to blood safety that may introduce additional costs. This study identifies costs that could be eliminated, thereby mitigating the financial impact. STUDY DESIGN AND METHODS: Cost information was obtained from five institutions on tests and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: McCullough, Jeffrey, Goldfinger, Dennis, Gorlin, Jed, Riley, William J, Sandhu, Harpreet, Stowell, Christopher, Ward, Dawn, Clay, Mary, Pulkrabek, Shelley, Chrebtow, Vera, Stassinopoulos, Adonis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Transfusion Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691315/
https://www.ncbi.nlm.nih.gov/pubmed/25989465
http://dx.doi.org/10.1111/trf.13149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691315/
https://www.ncbi.nlm.nih.gov/pubmed/25989465
http://dx.doi.org/10.1111/trf.13149

Ejemplares similares